Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Audiologic manifestations of patients with post treatment Lyme disease syndrome

Go back to Resources

Audiologic manifestations of patients with post treatment Lyme disease syndrome

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience

Go back to Resources

Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience

Authors:

Location:

Go back to Resources

Collaborative iIslet Transplant Registry

Go back to Resources

Collaborative iIslet Transplant Registry

Authors:

Secondary:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy

Go back to Resources

Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy

Authors:

Location:

Go back to Resources

Development of the National Eye Institute Refractive Error Correction Quality of Life Questionnaire (NEI-RQL) Part I: Focus Group

Go back to Resources

Development of the National Eye Institute Refractive Error Correction Quality of Life Questionnaire (NEI-RQL) Part I: Focus Group

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Dietary intake studies of antioxidants or zinc versus high-dose supplements in a randomized clinical trial; associations with cognitive impairment

Go back to Resources

Dietary intake studies of antioxidants or zinc versus high-dose supplements in a randomized clinical trial; associations with cognitive impairment

Authors:

Location:

Go back to Resources

Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review

Go back to Resources

Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis

Go back to Resources

A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A National Cancer Institute Pilot Study to Enhance Enrollment in Clinical Trials: The Expanded Participation Project (EPP)

Go back to Resources

A National Cancer Institute Pilot Study to Enhance Enrollment in Clinical Trials: The Expanded Participation Project (EPP)

Authors:

Location:

Go back to Resources

A prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation

Go back to Resources

A prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 139
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification